News

EMUC15: Best unmoderated posters in bladder and kidney cancers

The 7th EMUC has awarded today the three best unmoderated abstract posters to researchers from Italy, Israel and Belgium. Session chairpersons Profs. Bertrand Tombal and Harriet Thoeny cited the innovative approaches and insights on managing bladder and kidney cancers....

EMUC15: Challenges in kidney cancers

There are notable gains in the diagnosis of uncommon renal tumours but patients need to be enrolled in clinical studies or referred to high-volume centres for researchers to reach more meaningful outcomes.   “Non-clear cell renal cell carcinoma (nccRCC)...

EMUC15: Prostate cancer studies win best unmoderated poster awards

Three studies in prostate cancer treatment have won the best unmoderated posters at the second day of the 7th European Multidisciplinary Meeting on Urological Cancers (EMUC15). Researchers in the Netherlands, Italy and a multi-centre study involving institutions in France...

EMUC15: Bladder Cancer Updates on systemic treatments

Updates on systemic treatments for bladder cancer were discussed and examined in the second plenary session of the 7th European Multidisciplinary Meeting on Urological Cancers (EMUC15), with experts noting the small gains in drug therapy and possible prospects. Prof....

EMUC15: Systemic treatment for metastatic kidney cancer

New drug combinations, side-effects of systemic therapy and prospects in the management of renal cell carcinoma were taken up in the second plenary session of the 7th European Multidisciplinary Meeting on Urological Cancers  (EMUC15) with experts weighing in the...

EMUC15: Examining new issues and challenges in prostate cancer

From precision grading, imaging, genomics to epidemiology, a range of issues that impact prostate cancer therapies were examined by a multidisciplinary team of experts which gathered today in Barcelona for the 7th European Multidisciplinary Meeting on Urological Cancers (EMUC15)....

ESO conference tackles thorny prostate cancer issues

Controversial issues such as prostate cancer screening and the changing role of surgery in advanced diseased were discussed in the opening plenary session of the European School of Oncology (ESO) with experts acknowledging the role of timely screening while...

Understanding the role of biomarkers in PCa treatment

With the current emphasis on providing personalised treatment to prostate cancer patients, expectations on the role of biomarkers may have been too high and experts say delivering optimal management requires understanding the usefulness of biomarkers within the context of...